BioArctic signed the first deal for its “brain transporter” with Bristol Myers Squibb late last year. The deal is worth up to $1.4bn and allows the US drugmaker to start trials using the technology to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback